An observational study in Neuroma, sponsored by Medstar Health Research Institute. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-29.
Sponsored by Medstar Health Research Institute · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Neuroma with a site in United States — 4 open to participants now, 6 under way, none of them phase 3. Neuroma · United States.
Among the 25 studies in Neuroma with a site in United States, this one is one of 2 that started in 2021, is one of 7 observational ones, and was the 20th registered.
55 studies on the registry are indexed under Neuroma; 10 are open to participants now.
Browse Neuroma studies →4 of the 25 studies in Neuroma with a site in United States are open now. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 22+
University of Michigan · Sites in United States
Ages 22–75
The Methodist Hospital Research Institute · Sites in United States
Ages 18–90
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 7 Neuroma studies recruiting now, 4 set no upper age limit and 3 stop at 75 or younger; none take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 67 across 15 observational studies indexed under Neuroma.
Median enrollment 19 across the 18 interventional studies, 73 across the 7 observational. Of the 13 that completed or were terminated, 3 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 25 have an industry lead sponsor. The 10 most frequent:
Medstar Health Research Institute is the lead sponsor of 162 studies on the registry; 32 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 7 (50%) have results posted.
Medstar Health Research Institute has 1 study filed under Neuroma — fewer than ten, so there is no comparison to draw.
2 of the studies in Neuroma with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04865679Axogen CorporationTolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends | 2026-12 |
| NCT06915662Massachusetts General HospitalPain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 25 studies in Neuroma with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
This will be a prospective observational study that seeks to provide a comprehensive assessment of the outcomes after RPNI surgery compared to standard of care by utilizing multiple established and validated patient-reported outcomes measures, carefully tracking pre- and post-operative pain regimens, and performing functional and physiologic tests.
Patients 18 years or older with a history of digit, multi-digit or partial hand amputation. Patients must have discrete neuroma pain on clinical exam.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
symptomatic neuroma is excised, and the end of the peripheral nerve is implanted into a small denervated free muscle graft harvested from the patient
Procedure: Regenerative Peripheral Nerve Interface (RPNI) surgery
simple excision and traction neurectomy
Procedure: Traction Neurectomy
Surgeons will perform neuroma resection and RPNI creation using a free muscle graft from the brachioradialis muscle harvested through a small separate incision
Surgeons will perform neuroma resection and traction neurectomy,
Patient-Reported Outcomes Measurement Information System - Pain Interference (PROMIS-PI)
PROMIS Pain Interference (PROMIS-PI) scale measures the extent to which pain hinders an individual's engagement with physical, mental, cognitive, emotional, recreational, and social activities over the past 7 days answering each questions with a response of not at all, a little bit, somewhat, quite a bit, and very much with not at all being the best and very much the worst.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
Short-form McGill Pain Questionnaire (SF-MPQ-2)
theShort-form McGill Pain Questionnaire (SF-MPQ-2) measures 24 different qualities of pain and related symptoms using the intensity of pain and related symptoms felt during the past week on 0 to 10 scale, with 0 being no pain and 10 being the worst pain .
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
PROMIS Global Health (GH) v1.2
The Global Health Questionnaire contains 10 questions (7 general and 3 about the last 7 days). First 7 questions use a scale of excellent, very good, good, fair, and poor, poor being the worst with excellent being the best. The other three questions use different scales such as; never rarely, sometimes, often or always with never being the best and always being the worst; as well as none, mild, moderate, severe, very severe with none being the best and very severe being the worst; finally pain rating numbered 0-10 with 0 being no pain and 10 being the worst pain imaginable.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
Patient Health Questionnaire (PHQ-9),
The PHQ-9 form is a brief, self-administered questionnaire that assesses depression symptoms over the last 2 weeks consisting of 10 questions. 9 will be answered on a scale of 0-3 with 0 being the best and 3 bing the worst. The last question will use a response of not difficult at all, somewhat difficult, very difficult, and extremely difficult with not difficult at all being the best and extremely difficult being the worst.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
Generalized Anxiety Disorder measure (GAD-7),
Generalized Anxiety Disorder measure (GAD-7) is a screening tool and severity measure for generalised anxiety disorder (GAD) over the past 2 weeks consisting of 7 questions answered on a scale of 0-3 with 0 being the best and 3 being the worst.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
PC-PTSD-5
The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screening tool with 'Yes/No" answers designed to identify individuals with probable PTSD. Yes" answers represent the worst and "no" represents the best.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
PROMIS UpperExtremity (UE)
PROMIS UpperExtremity (UE) is designed to evaluate upper extremity function using a scale of 1-5 with 5 being the best possible answer and 1 being the worst.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
Brief Michigan Hand Outcomes Questionnaire (bMHQ)
The Brief Michigan Hand Outcomes Questionnaire (bMHQ) evaluates six upper extremity domains of function, activities of daily living(ADLs), aesthetics, performance,pain,and satisfaction using a scale of 1-5 with 5 being the best possible answer and 1 being the worst.
Time frame: Assessing change from Baseline to 1 week, 1 month, 3 months and 6 months
Grip Strength
A standard dynamometer will be used to evaluate grip strength
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Pinch Strength -Key and Three-point
Evaluate key pinch (thumb to radial border of index) and three-point pinch (index, middle, and thumb tips) strength.
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Range of Motion
Evaluate active and passive range of motion of all joints in the affected extremity proximal to the amputation stump, total active and passive range of motion of all unaffected digits on the ipsilateral hand, and total active motion of fall digits and wrist on the contralateral hand as an internal control
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Fine Motor Function - 9-Hole Peg Test (9HPT)
Evaluate timed exercise during which nine relatively small pegs are picked up, one at a time, and put into nine corresponding holes. The pegs are then removed from the holes (one at a time) and placed back in the starting bin.
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
FunctionalTask Testing - Lifting boxes
Evaluate whether the participant is able to perform the task, grip that was used, maximum weight used, and any compensatory findings. Subjects will be asked their pain level during each lift using a 10-point numerical scale
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Carrying Boxes
Evaluate whether the participant is able to perform the task, grip that was used, maximum weight used, and any compensatory findings. Subjects will be asked their pain level during each lift using a 10-point numerical scale
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Push/Pull sled
Evaluate whether the participant is able to perform the task, grip that was used, maximum weight used, and any compensatory findings. Subjects will be asked their pain level during each lift using a 10-point numerical scale
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Hammer
Evaluate tolerance for vibration and grip to perform a hammer task using
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Vice Grip
Evaluate vice grip Strength with all available digits using the Baltimore Therapeutic Equipment (BTE) PrimusRS work simulator.
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Gear Shifting
Evaluate ability to grip, push and pull gear shift with all available digits using the Baltimore Therapeutic Equipment (BTE) PrimusRS work simulator
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Functional Task Testing - Weapon Recoil
Evaluate the ability to preform this simulated task using the Baltimore Therapeutic Equipment (BTE) PrimusRS work simulator
Time frame: Assessing change from Baseline to 1 month, 3 months and 6 months
Plan to share: No
Started Oct 2021 (actual). Primary completion is estimated for Aug 2025, 46 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medstar Health Research Institute →